News

News
Partner news

Biocartis Completes €34,5 Million ($44,5 Million) Series D Fund Raising

Read full story
Partner news

23andMe Raises More than $50 Million in New Financing

Read full story
Partner news

PhaseBio Positions for the Next Stage of Development by Bringing on Board Industry Veteran, Jonathan Mow as Chief Business Officer

Read full story
Partner news

Genocea Closes $30 Million in Series C Financing

Read full story
Partner news

Lonza and Celladon Announce Manufacturing Agreement for MYDICAR®

Read full story
JNJ Press releases

Johnson & Johnson Announces Plans to Establish Innovation Centers

Read full story
Partner news

Celladon Corporation Announces First Patient Dosed in CUPID Phase 2b Trial of MYDICAR® for Advanced Heart Failure

Read full story
Partner news

Allergan and Molecular Partners Enter into Exclusive Alliance

Read full story
Partner news

PhaseBio Pharmaceuticals Initiates a Multicenter, Randomized Placebo and Active Comparator Controlled Phase 2b Trial to Evaluate use of Glymera for the Treatment of Uncontrolled Type 2 Diabetes

Read full story
Partner news

Genocea Initiates a Phase 1/2a Study with Its Therapeutic Vaccine Candidate for Herpes Simplex Virus-2 (HSV-2)

Read full story
Partner news

Publication of Clinical Trial Data for New Snoring Therapy

Read full story
Partner news

Celladon Corporation Receives Patent from United States Patent and Trademark Office

Read full story
Partner news

Lonza and BioWa Sign License Agreements with FivePrime Therapeutics for Use of Their POTELLIGENT® CHOK1SV Cell Line for Therapeutic Antibody Development

Read full story
Partner news

Astute Medical Completes $40.4 Million Series C Financing

Read full story
Partner news

PhaseBio Pharmaceuticals Received an Additional $23 Million with Completion of the Third Tranche of a Series B Financing for Advancement of Metabolic and Cardiovascular Product Portfolio

Read full story